Tate & Lyle said the document sets out the full terms of the proposed acquisition, which was to be implemented via a court‑sanctioned scheme of arrangement and will require approval from shareholders at both the court meeting and general meeting, scheduled for 28 July.
Subject to shareholder backing, court approval and satisfaction or waiver of the remaining conditions - including material antitrust clearances - the deal was expected to become effective in the second half of 2027.
Tate & Lyle noted that strong participation at the court meeting was important to demonstrate fair representation of shareholder opinion. Returning a proxy will not prevent shareholders from attending and voting in person.
The FTSE 250-listed firm said it continued to unanimously recommend the scheme, calling the financial terms "fair and reasonable". Advisers Goldman Sachs and Greenhill have provided independent financial advice to the directors, who have also irrevocably committed to vote in favour in respect of their own holdings.
As of 0815 BST, Tate & Lyle shares were up 0.072% at 556.40p.
Reporting by Iain Gilbert at Sharecast.com
See latest RNS at Investegate